Amylyx Pharmaceuticals, Inc. AMLX Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s investment purchases?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported investment purchases of $19.74M in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s investment purchases changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s investment purchases decreased by 81.0% year-over-year, from $103.65M to $19.74M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s investment purchases?
- Over 3 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s investment purchases has grown at a 67.8% compound annual growth rate (CAGR), from $49.05M to $231.82M.
- What does investment purchases mean?
- Cash spent purchasing investment securities across all categories.